{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:48:17Z","timestamp":1773204497256,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"vor","delay-in-days":193,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.ctarc.2025.100964","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:49:45Z","timestamp":1752616185000},"page":"100964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-7533","authenticated-orcid":false,"given":"Meaghan","family":"Polack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1449-7348","authenticated-orcid":false,"given":"Gabi W.","family":"van Pelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-4406","authenticated-orcid":false,"given":"Augustinus S.L.P.","family":"Crobach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1817-2743","authenticated-orcid":false,"given":"Lioe-Fee","family":"de Geus-Oei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6831-6082","authenticated-orcid":false,"given":"Rob A.E.M.","family":"Tollenaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-0450","authenticated-orcid":false,"given":"J.Han J.M.","family":"van Krieken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-4778","authenticated-orcid":false,"given":"Wilma E.","family":"Mesker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10207","key":"10.1016\/j.ctarc.2025.100964_bib0001","first-page":"1467","volume":"394","author":"Dekker","year":"2019","journal-title":"Colorectal Cancer. Lancet"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100964_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100964_bib0003","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/0115733947259130231003044741","article-title":"Early detection of colorectal cancer: conventional techniques and current biomarkers","volume":"20","author":"Ahmadpour","year":"2024","journal-title":"Curr. Cancer Ther. Rev"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0004","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/0115733947270529231116114913","article-title":"Alterations of the gut microbiome and metabolome following: a opportunity for early detection of colorectal cancer","volume":"21","author":"Modarres","year":"2025","journal-title":"Curr. Cancer Ther. Rev"},{"key":"10.1016\/j.ctarc.2025.100964_bib0005","series-title":"The TNM classification of malignant tumours","author":"Brierley","year":"2016"},{"issue":"10","key":"10.1016\/j.ctarc.2025.100964_bib0006","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argiles","year":"2020","journal-title":"Ann. Oncol."},{"issue":"Suppl 4","key":"10.1016\/j.ctarc.2025.100964_bib0007","doi-asserted-by":"crossref","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Glynne-Jones","year":"2018","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100964_bib0009","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC 8th edition: colorectal cancer","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"Pt 23","key":"10.1016\/j.ctarc.2025.100964_bib0010","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1242\/jcs.116392","article-title":"The tumor microenvironment at a glance","volume":"125","author":"Balkwill","year":"2012","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","article-title":"The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer","volume":"6","author":"Bremnes","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"10135","key":"10.1016\/j.ctarc.2025.100964_bib0012","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2025.100964_bib0013","article-title":"The effects of tumor-derived supernatants (TDS) on cancer cell progression: a review and update on carcinogenesis and immunotherapy","volume":"40","author":"Ahmadpour","year":"2024","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12672-024-01256-x","article-title":"The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets","volume":"15","author":"Lorestani","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ctarc.2025.100964_bib0015","first-page":"2024","article-title":"Whole-slide ECM imaging reveals dense fibrous matrix as a high-risk factor for recurrence in stage II colon cancer","author":"Ravensbergen","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100964_bib0016","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41416-019-0705-1","article-title":"The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome","volume":"122","author":"D'Arcangelo","year":"2020","journal-title":"Br. J. Cancer."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100964_bib0017","first-page":"15","article-title":"The impact of cancer-associated fibroblasts on the biology and progression of colorectal carcinomas","author":"Henrich","year":"2024","journal-title":"Genes. (Basel)"},{"issue":"9","key":"10.1016\/j.ctarc.2025.100964_bib0018","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2025.100964_bib0019","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/j.gastro.2016.11.049","article-title":"Mesenchymal cells in colon cancer","volume":"152","author":"Koliaraki","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12885-019-5462-2","article-title":"Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer","volume":"19","author":"Sandberg","year":"2019","journal-title":"BMC. Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100964_bib0021","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1158\/1078-0432.CCR-06-2191","article-title":"Stromal myofibroblasts predict disease recurrence for colorectal cancer","volume":"13","author":"Tsujino","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100964_bib0022","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s13277-012-0638-2","article-title":"High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis","volume":"34","author":"Wikberg","year":"2013","journal-title":"Tumour. Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100964_bib0023","first-page":"387","article-title":"The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage","volume":"29","author":"Mesker","year":"2007","journal-title":"Cell Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","article-title":"Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to cancer biology","volume":"38","author":"Nissen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2025.100964_bib0025","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fonc.2020.00979","article-title":"High expression of FAP in colorectal cancer is associated with angiogenesis and immunoregulation processes","volume":"10","author":"Coto-Llerena","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0026","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/annonc\/mds246","article-title":"The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial","volume":"24","author":"Huijbers","year":"2013","journal-title":"Ann. Oncol"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100964_bib0027","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41416-018-0083-0","article-title":"Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer","volume":"119","author":"Zunder","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2025.100964_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102988","article-title":"Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor\u2013stroma ratio in colon cancer","volume":"9","author":"Polack","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.ctarc.2025.100964_bib0029","first-page":"39","article-title":"The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer","volume":"20","author":"van Pelt","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100964_bib0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s12094-021-02746-y","article-title":"A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance","volume":"24","author":"Strous","year":"2022","journal-title":"Clin. Transl. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0031","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cjp2.143","article-title":"Preoperative, biopsy-based assessment of the tumour microenvironment in patients with primary operable colorectal cancer","volume":"6","author":"Park","year":"2020","journal-title":"J. Pathol. Clin. Res."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100964_bib0032","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cpet.2021.03.012","article-title":"The role of fibroblast activation protein ligands in oncologic PET imaging","volume":"16","author":"Dendl","year":"2021","journal-title":"PET. Clin."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100964_bib0033","first-page":"13","article-title":"Cancer-associated fibroblasts as players in Cancer development and progression and their role in targeted radionuclide imaging and therapy","author":"Koustoulidou","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"3","key":"10.1016\/j.ctarc.2025.100964_bib0034","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2025.100964_bib0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"(68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.ctarc.2025.100964_bib0036","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","article-title":"The role of (68)Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience","volume":"61","author":"Koerber","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2025.100964_bib0037","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.121.262426","article-title":"Correlation of (68)Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study","volume":"63","author":"Mona","year":"2022","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41416-022-01748-z","article-title":"Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by (68)Ga-FAPI-PET imaging","volume":"127","author":"Strating","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ctarc.2025.100964_bib0039","doi-asserted-by":"crossref","DOI":"10.1007\/s40336-023-00609-w","article-title":"Exploring the efficacy of FAPI PET\/CT in the diagnosis and treatment management of colorectal cancer: a comprehensive literature review and initial experience","author":"Dadgar","year":"2024","journal-title":"Clin. Transl. ImAging"},{"issue":"11","key":"10.1016\/j.ctarc.2025.100964_bib0040","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.ctarc.2025.100964_bib0041","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00428-018-2408-z","article-title":"Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations","volume":"473","author":"van Pelt","year":"2018","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.ctarc.2025.100964_bib0042","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/path.1621","article-title":"Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour","volume":"204","author":"Nagtegaal","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.ctarc.2025.100964_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101862","article-title":"Tumour-stroma ratio to predict pathological response to neo-adjuvant treatment in rectal cancer","volume":"45","author":"Strous","year":"2022","journal-title":"Surg. Oncol."},{"issue":"02","key":"10.1016\/j.ctarc.2025.100964_bib0044","first-page":"1","article-title":"Stroma-high lymph node involvement predicts poor survival more accurately for patients with stage III colon cancer","author":"van Pelt","year":"2016","journal-title":"J. Med. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.ctarc.2025.100964_bib0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0463.2006.apm_304.x","article-title":"Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum","volume":"114","author":"Prall","year":"2006","journal-title":"APMIS"},{"issue":"12","key":"10.1016\/j.ctarc.2025.100964_bib0046","first-page":"13","article-title":"Fibroblast activation protein alpha (FAP\u03b1) in fibrosis: beyond a perspective marker for activated stromal cells?","author":"Basalova","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100964_bib0047","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/his.13489","article-title":"The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact","volume":"73","author":"van Pelt","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.ctarc.2025.100964_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1339050","article-title":"Association of future cancer metastases with fibroblast activation protein-\u03b1: a systematic review and meta-analysis","volume":"14","author":"Janani","year":"2024","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100964_bib0049","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejso.2013.10.029","article-title":"EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: the radiology experts review","volume":"40","author":"Tudyka","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2025.100964_bib0050","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ejso.2018.04.008","article-title":"Clinical lymph node staging in colorectal cancer; a flip of the coin?","volume":"44","author":"Brouwer","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2025.100964_bib0051","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","article-title":"Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting","volume":"28","author":"Beets-Tan","year":"2018","journal-title":"Eur. Radiol."},{"issue":"11","key":"10.1016\/j.ctarc.2025.100964_bib0052","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1007\/s00259-022-05839-0","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 PET\/CT and [18F]FDG PET\/CT in colorectal cancer","volume":"49","author":"K\u00f6mek","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"13","key":"10.1016\/j.ctarc.2025.100964_bib0053","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1007\/s00259-023-06351-9","article-title":"[18F] AlF\u2011NOTA\u2011FAPI\u201104 PET\/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with 18F-FDG","volume":"50","author":"Yang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ctarc.2025.100964_bib0054","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-022-02832-9","article-title":"Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET\/CT","author":"Polack","year":"2022","journal-title":"Clin. Transl. Oncol"},{"issue":"20","key":"10.1016\/j.ctarc.2025.100964_bib0055","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1002\/cam4.3323","article-title":"Intratumor heterogeneity: a new perspective on colorectal cancer research","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.ctarc.2025.100964_bib0056","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ctarc.2025.100964_bib0057","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/bjs\/znad051","article-title":"Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & wait Database (IWWD)","volume":"110","author":"Temmink","year":"2023","journal-title":"Br. J. Surg"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0058","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2025.100964_bib0059","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00259-023-06107-5","article-title":"68Ga]Ga-FAPI-04 PET\/CT on assessing Crohn\u2019s disease intestinal lesions","volume":"50","author":"Chen","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1142","key":"10.1016\/j.ctarc.2025.100964_bib0060","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/CT imaging","volume":"96","author":"Hotta","year":"2023","journal-title":"Br. J. Radiol"},{"issue":"Suppl 2","key":"10.1016\/j.ctarc.2025.100964_bib0061","doi-asserted-by":"crossref","first-page":"13s","DOI":"10.2967\/jnumed.118.220566","article-title":"Future of Theranostics: an outlook on precision oncology in nuclear medicine","volume":"60","author":"Langbein","year":"2019","journal-title":"J. Nucl. Med"},{"issue":"8","key":"10.1016\/j.ctarc.2025.100964_bib0062","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20140692","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"211","author":"Ohlund","year":"2014","journal-title":"J. Exp. Med"},{"issue":"12","key":"10.1016\/j.ctarc.2025.100964_bib0063","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100964_bib0064","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med"},{"issue":"5","key":"10.1016\/j.ctarc.2025.100964_bib0065","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5642","article-title":"Heterogeneity of primary and metastatic CAFs: from differential treatment outcomes to treatment opportunities (Review)","volume":"64","author":"Kou","year":"2024","journal-title":"Int. J. Oncol"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0066","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41467-019-14134-w","article-title":"Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms","volume":"11","author":"Pelon","year":"2020","journal-title":"Nat. Commun"},{"issue":"5","key":"10.1016\/j.ctarc.2025.100964_bib0067","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jcmgh.2024.01.013","article-title":"Fibroblasts in orchestrating colorectal tumorigenesis and progression","volume":"17","author":"Abudukelimu","year":"2024","journal-title":"Cell Mol. Gastroenterol. Hepatol"},{"issue":"7","key":"10.1016\/j.ctarc.2025.100964_bib0068","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","article-title":"Principles and approaches for reproducible scoring of tissue stains in research","volume":"98","author":"Meyerholz","year":"2018","journal-title":"Lab. Invest"},{"issue":"1","key":"10.1016\/j.ctarc.2025.100964_bib0069","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ilar\/ily025","article-title":"Fundamental concepts for semiquantitative tissue scoring in translational research","volume":"59","author":"Meyerholz","year":"2018","journal-title":"ILAR. J"},{"key":"10.1016\/j.ctarc.2025.100964_bib0070","article-title":"Deep learning based tumor-stroma ratio scoring in colon cancer correlates with microscopic assessment","volume":"14","author":"Smit","year":"2023","journal-title":"J. Pathol. Inf."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294225001005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:57:56Z","timestamp":1762628276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294225001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":70,"alternative-id":["S2468294225001005"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100964","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast activation protein-expression in colorectal carcinomas and implications for clinical application","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2025.100964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100964"}}